BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6507136)

  • 21. The value of complete lymphadenectomy in radical treatment of cancer of the cervix, Stage IB.
    Kjorstad KE; Kolbenstvedt A; Strickert T
    Cancer; 1984 Nov; 54(10):2215-9. PubMed ID: 6488140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretreatment staging of cervical cancer: is imaging better than palpation?: Role of CT and MRI in preoperative staging of cervical cancer: single institution results for 255 patients.
    Hancke K; Heilmann V; Straka P; Kreienberg R; Kurzeder C
    Ann Surg Oncol; 2008 Oct; 15(10):2856-61. PubMed ID: 18696156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183.
    Hricak H; Gatsonis C; Chi DS; Amendola MA; Brandt K; Schwartz LH; Koelliker S; Siegelman ES; Brown JJ; McGhee RB; Iyer R; Vitellas KM; Snyder B; Long HJ; Fiorica JV; Mitchell DG; ;
    J Clin Oncol; 2005 Dec; 23(36):9329-37. PubMed ID: 16361632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doppler Ultrasound Flow Evaluation of the Uterine Arteries Significantly Correlates with Tumor Size in Cervical Cancer Patients.
    Bolla D; In-Albon S; Papadia A; Di Naro E; Gasparri ML; Mueller MM; Raio L
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S959-63. PubMed ID: 26036189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adenocarcinoma of the uterine cervix].
    Inoue Y; Noda K
    Gan No Rinsho; 1989 Oct; 35(13):1610-4. PubMed ID: 2685397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients.
    Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Ferrandina G; Legge F; Parazzini F; Scambia G; Schneider A; Vercellino GF
    Int J Gynecol Cancer; 2014 Jun; 24(5):916-22. PubMed ID: 24442006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The promise of image-guided brachytherapy of better clinical outcomes in treatment of cervical cancer: Does it deliver? An Indian scenario.
    Tiwari R; Narayanan GS; Jayakumar V; Narayanan S; Vishwanathan B; Mandal SK; Babu S; Ramya V; George D
    Gynecol Oncol; 2018 Sep; 150(3):420-425. PubMed ID: 30017538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histologic grade and prognosis of carcinoma of the cervix.
    Chung CK; Stryker JA; Ward SP; Nahhas WA; Mortel R
    Obstet Gynecol; 1981 May; 57(5):636-42. PubMed ID: 7219913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosquamous carcinoma of the cervix: prognosis in stage IB.
    Yazigi R; Sandstad J; Munoz AK; Choi DJ; Nguyen PD; Risser R
    Obstet Gynecol; 1990 Jun; 75(6):1012-5. PubMed ID: 2342726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should Systematic Infrarenal Para-aortic Dissection Be the Rule in the Pretherapeutic Staging of Primary or Recurrent Locally Advanced Cervix Cancer Patients With a Negative Preoperative Para-aortic PET Imaging?
    Leblanc E; Katdare N; Narducci F; Bresson L; Gouy S; Morice P; Ferron G; Querleu D; Martinez A
    Int J Gynecol Cancer; 2016 Jan; 26(1):169-75. PubMed ID: 26569062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy and survival of early invasive carcinoma of the cervix uteri with metastases to the pelvic nodes.
    Jobson VW; Girtanner RE; Averette HE
    Surg Gynecol Obstet; 1980 Jul; 151(1):27-9. PubMed ID: 7384981
    [No Abstract]   [Full Text] [Related]  

  • 32. F18-FDG-PET/CT in the evaluation of patients with suspected recurrent or persistent locally advanced cervical carcinoma.
    Cetina L; Serrano A; Cantú-de-León D; Pérez-Montiel D; Estrada E; Coronel J; Hernández-Lucio M; Dueñas-González A
    Rev Invest Clin; 2011; 63(3):227-35. PubMed ID: 21888286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent Chemoradiation with Weekly Paclitaxel and Cisplatin for Locally Advanced Cervical Cancer.
    Kalaghchi B; Abdi R; Amouzegar-Hashemi F; Esmati E; Alikhasi A
    Asian Pac J Cancer Prev; 2016; 17(S3):287-91. PubMed ID: 27165240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer.
    Oh D; Lee JE; Huh SJ; Park W; Nam H; Choi JY; Kim BT
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):549-54. PubMed ID: 24074928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laparoscopic lymph node dissection should be performed before fertility preserving treatment of patients with cervical cancer.
    Vercellino GF; Piek JM; Schneider A; Köhler C; Mangler M; Speiser D; Chiantera V
    Gynecol Oncol; 2012 Sep; 126(3):325-9. PubMed ID: 22704949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
    Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
    Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent carcinoma of the cervix: CT diagnosis.
    Walsh JW; Amendola MA; Hall DJ; Tisnado J; Goplerud DR
    AJR Am J Roentgenol; 1981 Jan; 136(1):117-22. PubMed ID: 6779557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
    Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
    Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.